NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Dopamine and Sensorimotor Function in Stuttering

RecruitingPhase 1

Sponsor: University of California, San Francisco

Conditions: Stuttering, Adult

Interventions: Aripiprazole 10 MG, Placebo

Countries: United States

This study is being done to understand the effect of aripiprazole on adults who stutter. Stuttering is a disorder that affects speech fluency. This study aims to understand sensorimotor pathways of stuttering and possible interventions.

Eligibility overview

Sex: ALL

Age: 18 Years to 65 Years

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* native speakers of American English
* for adults who stutter, presence of stuttering will be confirmed, with onset before age 6 years
* Normal hearing
* Ages of 18 to 65 years
* healthy adults without hearing-language difficulties

Exclusion Criteria:

* self-reported speech-language-hearing difficulties other than stuttering
* self-reported neurological or psychological problems
* other medications (drugs that affect dopaminergic system and/or benzodiazepines)

Locations (1)

San Francisco, California, United States